Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:12:05.362Z.
Calculation as of: 2026-10-06T14:12:05.362Z.
Quote observation: 2026-10-06T14:10:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8ce36116f6c4cf8d6fa5d70ec9ce1d9cbc86489a03ebd5e18b87b9f8ced35068
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$1.50B
Free Cash Flow Yield
0.98%
TTM Avg
2.60%
3Y Avg
3.83%
5Y Avg
3.74%
Market Cap
$1.53B
Free Cash Flow Yield
12.28%
TTM Avg
10.90%
3Y Avg
11.74%
5Y Avg
15.73%
Market Cap
$1.47B
Free Cash Flow Yield
10.34%
TTM Avg
10.16%
3Y Avg
6.41%
5Y Avg
5.78%
Market Cap
$1.45B
Free Cash Flow Yield
N/A
TTM Avg
14.53%
3Y Avg
14.53%
5Y Avg
14.53%
Market Cap
$1.43B
Free Cash Flow Yield
1.26%
TTM Avg
0.66%
3Y Avg
0.66%
5Y Avg
1.32%
Market Cap
$1.40B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GH Research PLC (GHRS) | $1.49B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 0.98% | 2.60% | 3.83% | 3.74% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.46B | N/A | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.53B | 12.28% | 10.90% | 11.74% | 15.73% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 10.34% | 10.16% | 6.41% | 5.78% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | N/A | 14.53% | 14.53% | 14.53% |
| Certara, Inc. (CERT)vs › | $1.54B | 4.01% | 6.20% | 4.05% | 3.26% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 1.26% | 0.66% | 0.66% | 1.32% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.35B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
